Bangladesh vs Chile: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Bangladesh
94.0%
in 2025
Chile
94.0%
in 2025
Bangladesh rank
44th
Chile rank
44th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Bangladesh
- Chile
How they compare
Bangladesh currently reports 94.0% against 94.0% in Chile, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Chile ahead.
Bangladesh ranks 44th and Chile ranks 44th of 192 countries.
Across the 3 decades both report, Bangladesh averaged higher in 1 and Chile in 1.
Head to head by decade
| Decade | Bangladesh | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 44.1% | 77.1% | 33.0% | Chile |
| 2020s | 96.8% | 92.3% | 4.5% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Bangladesh or Chile?
- Bangladesh, at 94.0% against 94.0% in Chile as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Bangladesh and Chile?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Chile?
- 18 years are reported by both, from 2008 to 2025.
- How do Bangladesh and Chile rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Bangladesh ranks 44th and Chile ranks 44th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.